Skip to content

Amgen AMGN Total costs & expenses

Total costs & expenses at other companies

Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
Abbott logo
AbbottABT
ALN
Alnylam PharmaceuticalsALNY
United Therapeutics logo
United TherapeuticsUTHR
Biogen logo
BiogenBIIB

Other financials

Income statement

See full
Revenue$8.6B+5.8%
Gross profit$5.9B+13.4%
Operating income$2.7B+126%
Net income$1.8B+5.1%
EPS (diluted)$3.34+4.4%

Balance sheet

See full
Cash & equivalents$559.0M+10.0%
Total debt$57.3B-0.1%
Total equity$9.2B+48.1%
Total assets$92.5B+3.5%

Cash flow

See full
Operating cash flow$2.2B+57.4%
CapEx$712.0M+73.2%
Free cash flow$1.5B+50.7%

Valuation

See full
Market cap$184.4B+13.3%
Enterprise value$241.16B+9.9%
P/E23.6×-3.8×
P/S+0.2×

Profitability

See full
Gross margin68.3%+5.3pp
Operating margin28.4%+6.6pp
Net margin21%+3.6pp

Returns & leverage

See full
Return on equity101.3%-4.4pp
Debt / equity6.2×-3.0×
Current ratio1.3×+0.1×

Where this comes from

Reported directly by Amgen in its filing.

Tagged under the XBRL concept us-gaap:CostsAndExpenses.

The official record: Amgen’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Amgen's total costs & expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Amgen's total costs & expenses?
Amgen (AMGN) reported total costs & expenses of $5.95B in Q1 2026.
How has Amgen's total costs & expenses changed year-over-year?
Amgen's total costs & expenses decreased by 14.6% year-over-year, from $6.97B to $5.95B.
What is the long-term trend for Amgen's total costs & expenses?
Over 4 years (2021 to 2025), Amgen's total costs & expenses has grown at a 10.8% compound annual growth rate (CAGR), from $18.34B to $27.67B.